Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 ☆
Titel:
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 ☆
Auteur:
Melero, I. Yau, T. Kang, Y.-K. Kim, T.-Y. Santoro, A. Sangro, B. Kudo, M. Hou, M.-M. Matilla, A. Tovoli, F. Knox, J. He, A.R. El-Rayes, B. Acosta-Rivera, M. Lim, H.Y. Soleymani, S. Yao, J. Neely, J. Tschaika, M. Hsu, C. El-Khoueiry, A.B.